Skip to content

Viant Explores Options Including Sale That Might Fetch Around $3 Billion

  • Water Street-backed medical device maker talking with advisers
  • Water Street says it isn’t exploring sale at this time
Updated on

Medical device maker Viant is exploring strategic options including a potential sale that could value it at $2 billion to $3 billion and perhaps more, according to people familiar with the matter.

The company, backed by health-care focused private equity firm Water Street, has been talking to advisers and a sale process could begin this year, said the people, who asked not to be identified because the discussions were private. The company, based in Foxborough, Massachusetts, generates $200 million a year in earnings before interest, taxes, depreciation and amortization, the people said.